ZOMETA®(Zoledronic acid )—Bone-targeted Therapy That Helps Reduce and Delay Skeletal-related Events (SREs) Across Multiple Solid Tumour Types | |
ZOMETA is indicated for the prevention of skeletal-related events (SREs) in multiple types of advanced cancer involving bone | |
Keywords : zometa, zoledronic acid, zometa cancer, zometa advanced cancer, zometa metastatic cancer, zoledronic acid zometa, zometa.com, www.zometa.com, zometa Novartis, zoledronic, bisphosphonate, bisphosphonates, bisphosphonate infusion, zometa infusion, bisphosph | |
H1 tags : ZOMETA International Site for Healthcare Professionals Outside of the US; Summary of Product Characteristics | |
H2 tags : For non-US healthcare professionals: Get information about ZOMETA and its product characteristics. |
Last Update : | 05/January/2012 |
Google PR : | N/A |
Internal links : | 28 |
External links : | 9 |
Archive : | Check how did the site look in the past? |